Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: βCrizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical studyβ.
Dan Spiegelman, Prethy Rao, Andria L. Ford, Jonathan J. Miner, Rajendra S. Apte +1 more
Rajendra S. Apte, Wilson X. Wang, Vivian Chen, Mae Gordon, Julia Huecker +7 more